Eyelid mass as the presenting finding in a child with Down syndrome and acute megakaryoblastic leukemia

Claudio Sandoval1, Adam Davis, Somasundaram Jayabose

  • 1Department of Pediatrics, New York Medical College, Munger Pavilion, Room 110, Valhalla, NY 10595, USA. claudio_sandoval@nymc.edu

Pediatrics
|March 3, 2005
PubMed

Insights

Children with Down syndrome have a higher risk of acute megakaryoblastic leukemia (AML). Early recognition of AML symptoms, like an eyelid mass, is crucial for timely diagnosis and treatment in these children.

Area of Science:

  • Pediatric Oncology
  • Hematology
  • Genetics

Background:

  • Children with Down syndrome (DS) exhibit a significantly elevated risk for developing acute megakaryoblastic leukemia (AML).
  • Familiarity with the diverse clinical presentations of AML is essential for healthcare providers managing pediatric patients with DS.

Observation:

  • A case study involving a child diagnosed with acute AML is presented.
  • This child, who had Down syndrome, initially presented with a unilateral eyelid mass.

Findings:

  • The eyelid mass was observed approximately one month prior to the definitive diagnosis of acute AML.
  • This case highlights an unusual, potentially overlooked, presenting sign of AML in children with Down syndrome.

Implications:

  • Increased awareness among clinicians regarding atypical presentations of AML in pediatric Down syndrome patients is warranted.
  • Prompt investigation of new clinical signs in children with DS may facilitate earlier detection of hematologic malignancies.
  • This case underscores the importance of a comprehensive diagnostic approach for children with Down syndrome presenting with concerning symptoms.